InvestorNewsBreaks

Thursday Feb 15, 2024 - 2:45 pm

InvestorNewsBreaks — Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes on $10M Public Offering

Sunshine Biopharma (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, has closed on a firm commitment underwritten public offering. The offering is comprised of 71,428,571 units, including 26,428,571 common units and 45,000,000 prefunded units. According to the announcement, the offering is projected to result in approximately $10 million gross proceeds, before the deduction…

Thursday Feb 15, 2024 - 2:06 pm

InvestorNewsBreaks – Reborn Coffee, Inc. (NASDAQ: REBN) Secures $1M in Private Placement

Reborn (NASDAQ: REBN), a California-based retailer of specialty coffee, recently announced the closing of its non-brokered $1 million private placement investment from Farooq Arjomand, its chairman. At the closing, the company issued 1,666,667 shares of its common stock for proceeds of $1,000,000 for a purchase price $0.60 per share. Reborn Coffee intends to use the proceeds for working capital and general corporate purposes. “This private…

Thursday Feb 15, 2024 - 1:43 pm

InvestorNewsBreaks – Datasea Inc. (NASDAQ: DTSS) Collaborates to Bring Unique Platform to New Customers

Datasea (NASDAQ: DTSS) is a Nevada incorporated digital technology corporation engaged in innovative business segments for intelligent acoustics and 5G multimodal communication technology in China. The company has announced that on Feb. 2, 2024, Guozhong Times (Beijing) Technology Ltd., a subsidiary of the Chinese operating company contractually controlled by Datasea, has entered into a cooperation agreement with Hangzhou Chongda Technology Co., Ltd. (“Chongda”) to increase…

Thursday Feb 15, 2024 - 1:38 pm

InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Consolidate All Operations in New Boston-Based Facility

Pressure BioSciences (OTCQB: PBIO), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly enabling, pressure-based instruments and nanoemulsion products and services for the health and wellness, food and beverage, pharmaceutical, and other industries, has achieved a significant milestone in its accelerating growth journey. The company has consolidated its Boston-area operations, uniting all of its personnel into a single Boston…

Thursday Feb 15, 2024 - 1:19 pm

InvestorNewsBreaks – Vstock Transfer Expands IPO, Existing Public Companies Suite of Services

Vstock Transfer, a premier stock-transfer agent serving nearly 1,000 issuers, is expanding its services designed specifically for initial public offerings (I”POs”) and existing public companies. Vstock’s expanded offerings include shareholder meeting services, virtual meeting administration, proxy tabulation, document web hosting, inspector of election services, and notice and access material distribution. The new offerings reflect the company’s mission, which is to serve as a robust resource…

Thursday Feb 15, 2024 - 12:33 pm

InvestorNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Enters Strategic Agreement as It Begins Expansion into Europe

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced its entry into a distribution agreement with Q-chem, a pest control product supplier in the Netherlands. SenesTech has developed and is commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. “Q-chem is a perfect partner for SenesTech as we begin our expansion into Europe,…

Thursday Feb 15, 2024 - 11:30 am

InvestorNewsBreaks — Lucid Group Inc. (NASDAQ: LCID) Announces New Pricing, Benefits for Award-Winning Lucid Air

Lucid Group (NASDAQ: LCID), a company setting new standards for luxury electric experience with the Lucid Air, is committed to make it easier than ever to purchase the world's best electric vehicle: the Lucid Air. The company has announced pricing for the electric vehicle, with the Lucid Air Pure now priced from $69,900, the Air Touring is available from $77,900 and the Air Grand Touring from $109,900. In…

Thursday Feb 15, 2024 - 11:19 am

InvestorNewsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces New Rotomolded Boat Model, Inks Exclusive Florida Distribution Deal

Vision Marine Technologies (NASDAQ: VMAR), an innovator in the performance electric recreational boating industry, has unveiled its newest offering: the Phantom. The company announced the new rotomolded, recyclable and hard-to-damage boat at the Miami International Boat Show 2024. According to the announcement, the Phantom is a breakthrough in rotomolded boat design that offers significant market advantages through its economic and environmental benefits. The company anticipates…

Thursday Feb 15, 2024 - 11:12 am

InvestorNewsBreaks — Safety Shot (NASDAQ: SHOT) Announces Record-Breaking Pro Skateboarder as New Brand Ambassador

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has a new brand ambassador. The company announced that American professional skateboarder and businessperson Danny Way has joined Safety Shot. In his new brand ambassador role, Way will work to increase awareness of the world’s first patented wellness beverage designed to help people feel better faster by reducing blood alcohol content while also boosting clarity…

Thursday Feb 15, 2024 - 11:08 am

InvestorNewsBreaks — Good Gaming Inc. (GMER) Announces Series of Airdrops, Upcoming Launch of Galactic Acres(TM)

Good Gaming (OTCQB: GMER), an innovative brand creating unique interactive entertainment experiences since 2008, today announced plans for a series of airdrops commencing over the next several months for Galactic Acres(TM), the company’s first in a series of Web3-enhanced mobile games, premiering on Feb. 16, 2024. Galactic Acres represents a bold leap to intersect gaming and blockchain technology that promises players unparalleled freedom and ownership…

Thursday Feb 15, 2024 - 11:02 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Exercise of Warrants for ~$4M

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”)). The company today announced its entry into a definitive agreement for the immediate exercise of an outstanding common stock purchase warrant held by an institutional investor to purchase an…

Thursday Feb 15, 2024 - 10:00 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on $3.6M Registered Direct Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into definitive agreements. The agreements are for the purchase and sale of 1,558,443 shares of common stock (or common stock equivalents in lieu thereof) offered at $2.31 per share (or per common stock equivalent in lieu thereof). The agreements are part of a registered direct offering priced in adherence with NASDAQ rules.…

Thursday Feb 15, 2024 - 10:00 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Deployment of Outdoor Robots to Patrol Washington-Based Properties

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has deployed two more of its K5 Autonomous Security Robots (“ASRs”). The robots feature KSCP’s proprietary AI software, which provides for enhanced safety measures. The robots were sent to patrol a Washington casino and a security-services company; the security-services company recently became a reseller in the Knightscope Authorized Partner…

Thursday Feb 15, 2024 - 9:53 am

InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate in Winter Wrap-Up MicroCap Rodeo 2024 Virtual Conference

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, will be represented at this month’s Winter Wrap-Up MicroCap Rodeo 2024 Virtual Conference. According to the announcement, Processa CEO George Ng will be presenting during the four-day conference, which will be held Feb. 20–23, 2024. Ng’s…

Thursday Feb 15, 2024 - 9:15 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Positive Phase 3 Data for Its Non-Opioid Drug Candidate, Spotlighted in FN Media Group News Commentary

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, is announcing that people who are suffering from fibromyalgia pain but do not want to risk addiction to an opioid are closer to a new option for treatment. According to the announcement, the company announced positive Phase 3 study results for its non-opioid investigational drug candidate Tonmya or…

Wednesday Feb 14, 2024 - 3:11 pm

InvestorNewsBreaks – Rocket Lab USA Inc. (NASDAQ: RKLB) Closes on $355M Private Offering

Rocket Lab USA (NASDAQ: RKLB), a global leader in launch services and space systems, has closed on its private offering. The transaction was a $355 million principal amount of 4.250% convertible senior notes due 2029; the notes are due to those reasonably believed to be qualified institutional buyers. According to the announcement, the total amount of the offering comes from both the previously announced, upsized…

Wednesday Feb 14, 2024 - 1:30 pm

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Three New Contracts for Its Proprietary K1 Hemisphere Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has finalized three new contracts for its K1 Hemisphere. The contracts are with a commercial real estate company in California, a residential property in Illinois and a healthcare company in Minnesota. Calling the K1 Hemisphere “a perfect entry point into deploying Knightscope’s combination of robotics and artificial intelligence…

Wednesday Feb 14, 2024 - 1:18 pm

InvestorNewsBreaks – CEL-SCI Corporation (NYSE American: CVM) Closes on $7.75M Public Offering

CEL-SCI Corporation (NYSE American: CVM), a phase 3 cancer-immunotherapy company, has closed on its previously announced public offering. The offering was comprised of 3,875,000 shares of common stock, offered at $2 per share, resulting in $7.75 million in gross proceeds before deducting underwriting discounts and offering expenses. According to the announcement, CEL-SCI anticipates using the funds for continued development of Multikine as well as for…

Wednesday Feb 14, 2024 - 12:53 pm

InvestorNewsBreaks – DealFlow’s Activist Investor Conference 2024 to Showcase Industry’s Most Innovative and Transformative Ideas

DealFlow Events, renowned host and organizer of hundreds of investment themed conferences over the past two decades, today announced the Activist Investor Conference 2024. The leading forum for discussing governance-related issues relevant to investing professionals, the event is slated to take place on March 21, 2024, at Convene in New York City. First launched in 2010, DealFlow’s Activist Investor Conference 2024 provides unparalleled opportunities for…

Wednesday Feb 14, 2024 - 11:42 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Announces Partnership with First Commercial Dealership

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its subsidiary Bollinger Motors have announced that Bollinger has contracted with its first authorized dealership. Bollinger is partnering with LaFontaine Automotive Group, which has two locations in Michigan: Lansing and Farmington Hills. LaFontaine will offer the Bollinger B4 Chassis Cab, which is an all-new, all-electric class 4 commercial truck designed from the ground up…

Wednesday Feb 14, 2024 - 11:02 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Validation of Delivery System for SP-26

Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today provided a positive update on SP-26, its novel time-released, dose-controlled formulation of ketamine initially targeted for fibromyalgia. According to the announcement, a pre-clinical research study is underway involving analytical testing services and small batch proof-of-concept extrusion trials…

Wednesday Feb 14, 2024 - 10:57 am

InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ), Subsidiary Ink Multiyear Deal with Danziger Colombia

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) and its majority-controlled subsidiary, Eko2o Environmental Solutions S.A.S., have signed a multiyear contract with Danziger Colombia. According to the announcement, the agreement outlines plans for Colombia-based Eko2o, a leading provider of greenhouse infrastructure and agricultural technology, to provide greenhouse infrastructure services, irrigation products and technology to Danziger’s flower operations in Colombia. The company anticipates the agreement, which…

Wednesday Feb 14, 2024 - 10:32 am

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Welcomes Brand Ambassador and Internet OG Matthew Espinosa

Safety Shot (NASDAQ: SHOT) today announced that Matthew Espinosa joins Safety Shot as a brand ambassador to share his love and enthusiasm for the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Having amassed more than 16 million followers across social media, Matthew is a multiplatform entertainer who has been catering…

Wednesday Feb 14, 2024 - 10:22 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Q3 Results, Recent Business Highlights

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental health care by developing new and innovative next-generation psychedelic treatment options, today announced unaudited financial results for its third quarter ended Dec. 31, 2023, and recent business highlights. “During the past three months, we have continued to make exciting progress with positive topline data from our CYB003 and DMT programs,”…

Wednesday Feb 14, 2024 - 10:14 am

InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Unveils Small Business Solutions to Protect Against Cyber Attacks

Sekur Private Data (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, launched its Sekur SMB Privacy and Security solutions. The offerings are privacy communications solutions designed for use against increased cyber attacks and business email compromise (“BEC”) attacks on small businesses (“SMB”), particularly during the presidential election year. According to the announcement, the company is marketing the SMB solutions online with…

Wednesday Feb 14, 2024 - 10:07 am

InvestorNewsBreaks — Vistagen Therapeutics Inc.’s (NASDAQ: VTGN) Releases Q3 2024 Financial Report, Corporate Update

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders, is reporting its Q3 2024 financial numbers as well as providing an update on the company. Notable numbers from the report include research and development expenses reaching $4.5 million and $6.9 million for the three months ended Dec. 31, 2023 and 2022, respectively; general and…

Wednesday Feb 14, 2024 - 9:53 am

InvestorNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Opens Up Access to the Newest Advantage2(TM) Prototype

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, has announced that the Advantage2 prototype, which features 1,200+ qubits and 10,000+ couplers, is now available via the company’s LeapTM real-time quantum cloud service. According to D-Wave, customers with Leap service subscriptions can access the new…

Wednesday Feb 14, 2024 - 9:48 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Numbers for Q2 2024, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on its financial results for Q2 2024, the period ended Dec. 31, 2023. The company also provided a corporate update, including plans to advance two preclinical programs in Alzheimer's and age-related macular degeneration. Highlights of the report included that the company closed the 2023…

Wednesday Feb 14, 2024 - 9:15 am

InvestorNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Releases Q4, FY 2023 Financial Report

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, is reporting unaudited financial results for the fourth quarter and year ended December 31, 2023; that report includes contributions from European iGaming operator, SuprNation, which DoubleDown acquired in October 2023. Highlights of the report included $83.1 million revenue in the fourth quarter of 2023 compared to $76.2 million…

Wednesday Feb 14, 2024 - 8:30 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Holds Webinar to Discuss Positive Phase 3 Fibromyalgia Data, NDA Filing Plans

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, recently held a key opinion leader (“KOL”) webinar hosted by Alliance Global Partners (“AGP”). The webinar featured two thought leaders in the field of fibromyalgia, Dr. Daniel Clauw and Dr. Lesley Arnold. The thought leaders discussed the positive data from a Phase 3 study of Tonmya(TM) (also known…

Tuesday Feb 13, 2024 - 1:52 pm

InvestorNewsBreaks – IBN’s CNW to Elevate Visibility for ZJ Events in 2024

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands within IBN (“InvestorBrandNetwork”), has announced its renewed partnership as the official newswire for ZJ Events in 2024. ZJ Events, an innovative organizer hosting multiple trade shows across the USA and South America every year, is set to deliver a captivating 2024 event series, featuring the BizCann Expo and Alternative…

Tuesday Feb 13, 2024 - 1:46 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Financial Report, Company Update on ‘Strongest Quarter to Date’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting financial results for the three months ended Dec. 31, 2023; the company is also reporting a business update. Highlights of the report included the company regaining compliance with the NASDAQ minimum-bid price requirement in January; the achievement of several key milestones, including CARB and federal EPA and NHTSA certification for its Class 1…

Tuesday Feb 13, 2024 - 1:43 pm

InvestorNewsBreaks – DealFlow’s Upcoming Conference to Showcase Innovative Products and Services in the Alternative Financing Space

DealFlow Events, host and organizer of hundreds of investment themed conferences over the past two decades, today announced the 2nd Annual Venture Debt Conference 2024. As the world’s largest forum dedicated to non-dilutive financing strategies for emerging growth companies, the event is slated to take place on March 6, 2024, at the historic Edison Ballroom in New York City. The full-day forum will focus on…

Tuesday Feb 13, 2024 - 1:14 pm

InvestorNewsBreaks – Nextech3D.ai (CSE: NTAR) (OTCQX: NEXCF) (FSE: 1SS) Lands $1.8M Deal, Demonstrating Scalability of Its Technology

Nextech3D.AI (CSE: NTAR) (OTCQX: NEXCF) (FSE: 1SS), a generative AI-powered 3D model supplier for major e-commerce retailers, today announced a significant $1.8 million 3D modeling contract with a major enterprise client. The deal provides significant revenue to be delivered in 2024 for the company and showcases Nextech3D.ai’s position as an industry leader for 3D modeling in the $6.3 trillion e-commerce market*. “Nextech3D.ai has been at…

Tuesday Feb 13, 2024 - 12:51 pm

InvestorNewsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR) Names MarineMax Executive to Board

Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, announced that Anthony E. Cassella Jr., executive vice president finance and chief accounting officer at MarineMax Inc. (NYSE: HZO) has been appointed to its board of directors; Cassella will serve as an independent director. According to the announcement, the appointment reflects VMAR’s leading role in marine technology innovation…

Tuesday Feb 13, 2024 - 12:43 pm

InvestorNewsBreaks – Optec International Inc. (OTC: OPTI) Focus of Judgment, RB Capital Provides Shareholder Update

Optec International (OTC: OPTI) is the focus of a judgment filed by California-based RB Capital Partners Inc., a private investment fund. A recent announcement noted that RB Capital was clarifying the judgment and releasing a shareholder update. According to the announcement, RB Capital observed that it was the largest investor and legitimate shareholder of OPTEC and was “forced to bring a shareholder derivative action against…

Tuesday Feb 13, 2024 - 12:34 pm

InvestorNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’

Renovaro (NASDAQ: RENB) today announced the completion of its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, marking a new era in healthcare innovation. According to the announcement, the two subsidiaries will be under the…

Tuesday Feb 13, 2024 - 12:04 pm

InvestorNewsBreaks – GEMXX Corp. (GEMZ) Announces Groundbreaking Start for January Product Deliveries

GEMXX (OTC: GEMZ), a pioneering mine-to-market gold, gemstone and jewelry producer, today announced a stellar start to the year with impressive product deliveries worth $1,051,374 at retail for the month of January. According to the announcement, January’s deliveries mark an incredible 600% increase compared to the same period last year, highlighting GEMXX's strong growth trajectory and its effective business strategies. “Our January delivery results are…

Tuesday Feb 13, 2024 - 11:25 am

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Launches Article Automation Feature, Enabling Cutting-Edge Content Generation

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. The company today announced it is offering additional customizations empowering instructors to select from five different types of resources (including news, magazines, academic journals, market reports and press releases) to bring into their programs. The technology enables continuous and contextual updates to program materials by…

Tuesday Feb 13, 2024 - 11:20 am

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as head of business development and sales. Halpert brings extensive pharmaceutical sales and marketing experience and joins Scinai following 14 years at Novartis, most recently having served as marketing and commercial excellence…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions